Alicia Olivo's Planned Sale of NeoGenomics Inc. Common Stock

Alicia Olivo, an officer of NeoGenomics Inc., has filed a Form 144 notice indicating her intention to sell 4,918 shares of common stock. The shares were acquired as Restricted Stock Units on May 11, 2024, and are planned to be sold on October 16, 2025. The aggregate market value of the shares to be sold is approximately $49,032.46. The sale will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services. There are no reported transactions in the past three months. The filing is a routine disclosure of planned stock sales by an officer of the company.